Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

Philips

AGFA 1400x150

Petal Health

Petal Health 1400x150

Clinical Solutions

MRI-guided laser surgery used at Vancouver General

March 4, 2015


Dr Brian Toyota

VANCOUVER – Dr. Brian D. Toyota (pictured), head of the division of neurosurgery at the University of British Columbia, has performed Canada’s first NeuroBlate procedure at Vancouver General Hospital. NeuroBlate is currently the only minimally invasive robotic laser thermotherapy tool available in Canada, following Health Canada licensing late last year.

Dr. Toyota used the NeuroBlate System’s magnetic resonance imaging (MRI) and software-based visualization to ablate a tumor in a Canadian patient’s brain.

“With NeuroBlate, we aim to remove the diseased tissue while protecting the healthy tissue around it as much as possible. In some situations we can remove the vast majority of the tumor, with a minimally invasive procedure that may allow the patient to even walk out of the hospital in about 24 hours,” said Dr. Toyota.

“I am proud to be the first surgeon in Canada to use this technology, but even more I am especially pleased with how well it worked. The patient was in a dire situation, but the procedure went very well and his post-operative recovery was remarkable.”

NeuroBlate was devised by Monteris Medical. The NeuroBlate System employs a pulsed surgical laser to deliver targeted energy to abnormal brain tissue such as tumors and other neurological soft tissue lesions.

With the NeuroBlate System, a surgeon makes a small hole in the skull, approximately as wide as a pencil. With precision, the surgeon then guides a small laser probe through the hole into the tumor. The probe delivers laser light energy to heat and destroy the tumor, through a process called ablation. The NeuroBlate System includes software that allows surgeons to precisely guide the ablation on a computer screen with MRI visualization.

With its minimally invasive and image-guided approach, the NeuroBlate System has shown results analogous to open surgery. However, because of its minimally invasive nature, patients undergoing procedures with the NeuroBlate System may experience less pain and reduced hospital length of stay compared with those undergoing open surgical procedures.

“Monteris Medical congratulates Dr. Toyota for conducting the first NeuroBlate procedure in Canada,” said John Schellhorn, President and CEO of Monteris Medical. “It is our hope that Canadian patients suffering from a variety of neuro pathologies will have access to a technology which enables them to have less traumatic neurosurgery experiences, with all of the benefits which that enables.”

About the NeuroBlate System®

The NeuroBlate System is Health Canada-licensed to necrotize or coagulate soft tissue encountered in the discipline of neurosurgery through the application of laser thermotherapy. Cleared by the U.S. Food and Drug Administration (FDA) in April 2013, the NeuroBlate System has been used in more than 300 surgical procedures in more than 22 leading institutions across the U.S., including Cleveland Clinic, Washington University, UC San Diego Health System and Yale New Haven Hospital. The NeuroBlate System is a tool (as opposed to a “treatment”) that can be used by physicians to address tumors and lesions. The NeuroBlate System is not intended to treat, cure, prevent, mitigate or diagnose any specific disease, e.g., cancer. Physicians should use their clinical judgment and experience when deciding to use the NeuroBlate System. The technology is not appropriate for every tumor/lesion type and location. For example, it may be difficult to use the technology on certain large or irregularly shaped tumors. Certain placements of the laser probe into the brain, or too much heat applied, may cause bleeding or permanent brain damage. Some patients have temporary swelling after the procedure that may cause short-term abnormal brain or nervous system function. Any medical situation, including NeuroBlate, that requires a patient to stay still for long periods can cause dangerous blood clots (deep venous thrombosis). Full prescribing information for the NeuroBlate System is available at www.monteris.com/IFU.

About Monteris Medical

Monteris Medical is a privately held company developing devices for minimally invasive, MR-guided neurosurgery. Monteris markets the NeuroBlate System for controlled, volumetric ablation of brain lesions. Monteris also offers the various Stereotactic anchoring devices for image-guided trajectory alignment, and the AtamA Stabilization System for MR based procedures requiring versatile head fixation. Now headquartered in Minneapolis, Minnesota, Monteris was founded in Winnipeg, Manitoba, and maintains a significant portion of its staff and operations there. For more information on Monteris Medical please visit www.monteris.com.

PreviousNext

CHT print

CHT print

e-Messenger

  • Niagara Health to deploy top-flight CT scanners
  • BC extends cost-reduction search to regional authorities
  • Osler uses Sectra’s AI service to enhance patient care
  • Waypoint Centre to deploy A4i platform
  • Island Health brings virtual psychiatry to rural communities
More from e-Messenger

Subscribe

Subscribe

Weekly blasts are sent each month, via e-mail, to over 7,000 senior managers and executives in hospitals, clinics and health regions. Learn More

Infoway

Infoway

Zebra

Zebra

Zebra

Zebra

Advertise with us

Advertise with us

Sectra KLAS

Sectra KLAS

Stratford Group

Stratford Group

Pure Storage

Pure Storage

Medirex

Medirex

NIHI

NIHI

CHT print

CHT print

Advertise with us

Advertise with us

Sectra KLAS

Sectra KLAS

Stratford Group

Stratford Group

Pure Storage

Pure Storage

Medirex

Medirex

NIHI

NIHI

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 204
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2025 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us